Combined Use of Prostate-specific Antigen Density and Magnetic Resonance Imaging for Prostate Biopsy Decision Planning: A Retrospective Multi-institutional Study Using the Prostate Magnetic Resonance Imaging Outcome Database (PROMOD)

Ugo Giovanni Falagario(Ospedali Riuniti di Foggia), Giuseppe Carrieri(University of Foggia), Oscar Selvaggio(University of Foggia), Luca Macarini(University of Foggia), Otto Ettala(University of Turku), Giorgio Gandaglia(Vita-Salute San Raffaele University), Erik Skaaheim Haug(Oslo University Hospital), Tobias Nordström(Karolinska Institutet), Ash Tewari(Royal Free London NHS Foundation Trust), Luigi Cormio(University of Foggia), Alberto Martini(The University of Texas MD Anderson Cancer Center), Anna Lantz(Mount Sinai Hospital), Ivan Jambor(University of Turku), Ileana Montoya Perez(University of Turku), Hannu J. Aronen(University Medical Center Utrecht), Pekka Taimen(University of Turku), Wolfgang Picker, Parita Ratnani(Mount Sinai Hospital), Juha Knaapila(University of Turku), Vito Cucchiara(IRCCS Ospedale San Raffaele), Armando Stabile(Royal Free London NHS Foundation Trust), Sara Lewis(Icahn School of Medicine at Mount Sinai), Nicola Fossati(Ospedale regionale di Lugano), Peter J. Boström(University of Turku), Nair Sujit(Icahn School of Medicine at Mount Sinai), Alberto Briganti(Vita-Salute San Raffaele University), Kenneth Haines(Mount Sinai Hospital), Francesca Sanguedolce(University of Foggia)
European Urology Oncology
September 21, 2020
Cited by 105


Related Papers